Free Trial
→ Consumer apocalypse imminent (7 ominous red flags) (From Stansberry Research) (Ad) Free NMRA Stock Alerts

Neumora Therapeutics (NMRA) SEC Filings & 10K Form

Neumora Therapeutics logo
$0.73 -0.02 (-3.12%)
As of 06/30/2025 04:00 PM Eastern
Compare

Recent Neumora Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
05/30/2025
5:25 PM		Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
5:30 PM		Halawa Alaa (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
5:30 PM		Ho Maykin (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
5:30 PM		BERNS PAUL L (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
5:30 PM		Neumora Therapeutics (Issuer)
Piacquad David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
5:30 PM		Aurora Daljit Singh (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
5:30 PM		Burow Kristina (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
5:30 PM		Fust Matthew K (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
5:30 PM		Duncan Jason (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
5:31 PM		Milligan Michael Lee (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
4:21 PM		Neumora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2025
3:42 PM		Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
11:15 PM		Neumora Therapeutics (Filer)
Form EFFECT
03/12/2025
3:49 PM		Gosebruch Henry O (Reporting)
Neumora Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
3:41 PM		Neumora Therapeutics (Filer)
Form POS AM
03/03/2025
3:44 PM		Neumora Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/03/2025
6:32 AM		Neumora Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/03/2025
6:06 AM		Neumora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2025
6:12 AM		Neumora Therapeutics (Filer)
Form POSASR
02/20/2025
4:11 PM		Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:12 PM		Lenz Robert A. (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:13 PM		Aurora Daljit Singh (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:14 PM		Milligan Michael Lee (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:14 PM		BERNS PAUL L (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM		Halawa Alaa (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM		Duncan Jason (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM		Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM		Milligan Michael Lee (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM		Burow Kristina (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM		Neumora Therapeutics (Issuer)
Piacquad David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM		Fust Matthew K (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM		Aurora Daljit Singh (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM		Ho Maykin (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM		Lenz Robert A. (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM		BERNS PAUL L (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
3:51 PM		Neumora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
7:00 AM		Neumora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
6:10 AM		Neumora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
4:01 PM		BERNS PAUL L (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
4:33 PM		ARCH Venture Fund XII, L.P. (Filed by)
Neumora Therapeutics (Subject)
Form SC 13D/A
11/12/2024
6:17 AM		Neumora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Here's the last trade you should make before heading out for the weekend tomorrow. (Ad)

Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.

Give me the details
10/18/2024
5:25 PM		Fust Matthew K (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
3:01 PM		Fust Matthew K (Reporting)
Neumora Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/17/2024
3:26 PM		Fust Matthew K (Reporting)
Neumora Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/11/2024
3:10 PM		Lenz Robert A. (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2024
3:30 PM		Lenz Robert A. (Reporting)
Neumora Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/09/2024
3:10 PM		Lenz Robert A. (Reporting)
Neumora Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/01/2024
4:22 PM		Neumora Therapeutics (Filer)
Form S-3ASR
09/19/2024
3:35 PM		Lenz Robert A. (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
3:37 PM		Lenz Robert A. (Reporting)
Neumora Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2024
4:22 PM		Aurora Daljit Singh (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
4:18 PM		Lenz Robert A. (Reporting)
Neumora Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/27/2024
4:58 PM		Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
5:17 PM		Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
8:48 AM		Neumora Therapeutics (Subject)
Pinto Joshua (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/06/2024
6:15 AM		Neumora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2024
3:15 PM		FMR LLC (Filed by)
Neumora Therapeutics (Subject)
Form SCHEDULE 13G
07/08/2024
12:07 PM		FMR LLC (Filed by)
Neumora Therapeutics (Subject)
Form SCHEDULE 13G
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:NMRA) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...
Brownstone Research | Sponsored
Utah’s New Oil Find
The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...
Stansberry Research | Sponsored
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsored
Elon’s Revenge
Elon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...
Altimetry | Sponsored
Buffett’s $325 Billion Cash Problem — Solved by Gold?
A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...
Golden Portfolio | Sponsored
The $15 Gold Fund That Pays Up to $1,152/Month
Gold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...
Investors Alley | Sponsored
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored